Type 2 diabetes drug combats Parkinson’s
A diabetes drug could be a breakthrough treatment for stopping Parkinson’s disease in its tracks, a study suggests.
People with Parkinson’s who took Exenatide – an existing diabetes medication – for around a year had better motor skills than those who took a placebo.
The results suggest the drug could halt decline in Parkinson’s patients rather than just relieving symptoms.
Experts welcomed the University College London (UCL) research as a ‘particularly promising’ step in the search for a treatment to slow or stop the disease.
The drug is modelled on the saliva of the Gila monster lizard and has been used since 2005 to treat Type 2 diabetes.
The research is published in The Lancet on Friday and was funded by the Michael J. Fox Foundation for Parkinson’s Research (MJFF).
In this article
Related
Latest
Get the latest news delivered straight to your inbox every day of the week. Stay informed with the Guardian’s leading coverage of Nigerian and world news, business, technology and sports.
0 Comments
We will review and take appropriate action.